Rejected at 11:29 p.m. Apr, 12, 2024 ] by Cameron
Author: dryas111
Related Note: 1474580923255
Rationale for change

theophylline antagonizes the Adenosine-1 receptor (A1), not the alpha-1 receptor (of the SNS).

Rejection reason

No source provided

Extra Extra
Text
Theophylline may have CNS side effects including {{c1::nervousness}} and {{c1::tremor}}
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy





Watch Asthma Therapy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo

Bootcamp
Watch associated Bootcamp video - Obstructive Lung Disease : Asthma Treatments

Watch associated Bootcamp video - Autonomic System : Phosphodiesterase Inhibitors
OME

Additional Resources
narrow therapeutic window that may be altered by drugs/illness that inhibit liver CYP-450
One by one
Empty field
#AK_Step1_v12::#Pixorize::^Missing_image #AK_Step1_v12::#AMBOSS::oxa0x5 #AK_Step1_v12::#B&B::18_Pulm::02_Obstructive_and_Restrictive_Diseases::04_Treatment_of_COPD_and_Asthma #AK_Step1_v12::#Physeo::09_Pharm::08_Respiratory::06_Asthma_Treatment #AK_Step1_v12::#FirstAid::05_Pharm::02_Autonomic_Drugs::16_Phosphodiesterase_inhibitors::*Methylxanthines::Theophylline #AK_Step1_v12::#AMBOSS::fOak7k #AK_Step2_v12::#UWorld::Step::4048 #AK_Step1_v12::#UWorld::COMLEX::23285 #AK_Step1_v12::^Systems::Respiratory::Pharmacology #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Step1_v12::#SketchyPharm::04_Smooth_Muscle::02_Allergy_&_Pulmonary::02_Asthma_therapy #AK_Step2_v12::Original_decks::Dorian::im::uw::pulm_cc #AK_Step1_v12::#UWorld::Step::11752 #AK_Step2_v12::#Resources_by_rotation::IM::uw::pulm_critical_care::pulm_critical_care_dorian #AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#Bootcamp::Pulmonology::05_Obstructive_Lung_Disease::03_Asthma_Treatments #AK_Step2_v12::#AMBOSS::CC0q8R #AK_Step1_v12::#AMBOSS::xlaE_k #AK_Step1_v12::#Pixorize::03_Pharmacology::20_Respiratory_Pharm::13_Theophylline #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::^Other::^HighYield::2-RelativelyHighYield #PANCE::EOR::PEDS #AK_Step2_v12::Original_decks::Zanki_Step_2::IM::Pulm_&_Critical_Care !AK_UpdateTags::Step1decks::Zanki-Pharmacology #AK_Step2_v12::#AMBOSS::oxa0x5 #AK_Step1_v12::#FirstAid::16_Respiratory::05_Pharm::05_Asthma_drugs #AK_Step1_v12::#Physeo::09_Pharm::08_Respiratory::07_Alternative_Asthma_Treatment #AK_Step1_v12::#FirstAid::16_Respiratory::05_Pharm::05_Asthma_drugs::06_Methylxanthines #AK_Step1_v12::#UWorld::Step::172 #PANCE::PULM::obstructive_pulmonary_diseases #AK_Step1_v12::#OME::PreClinical::General_Physiology::Smooth_Muscle #AK_Step2_v12::#Resources_by_rotation::IM::uw::pulm_critical_care::pulm_critical_care_zanki #AK_Step1_v12::#Bootcamp::Pharmacology::03_Autonomic_System::17_Phosphodiesterase_Inhibitors #AK_Step1_v12::#UWorld::COMLEX::25645 #AK_Step2_v12::#UWorld::COMLEX::100838